Pomegranate Extract Enzymatic Processing for Influenza Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack an effective prophylactic solution for reducing the incidence of influenza virus infections, as existing antioxidants do not adequately address the high mutation rate and cross-species transmission of influenza viruses, and there is a need for anti-viral mechanisms not affected by antigenic drift.
Innovation Solution
A method for producing an extract from pomegranate solids, including the pericarp, inner membrane, and seeds, which is combined with an aqueous solution, heated, and treated with enzymes to liberate phytochemicals, resulting in a composition with higher polyphenol content, particularly punicalagin, that can be used as an anti-viral composition to reduce influenza virus infection incidence.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional pomegranate juice is used as an antioxidant source, then it provides some polyphenol content, but it lacks sufficient high molecular weight polyphenols like punicalagin needed for effective anti-viral activity against influenza
Solution Approach 1:
The patent extracts and concentrates high molecular weight polyphenols, particularly punicalagin, from pomegranate solids through a multi-step process involving enzymatic treatment, filtration, and concentration. This extraction isolates the specific anti-viral active components from the whole fruit, achieving much higher concentrations (up to 100 times more punicalagin than commercial juice) to effectively combat influenza viruses
Solution Approach 2:
The patent creates a composite antioxidant composition by combining multiple polyphenolic compounds (punicalagin, punicalin, ellagitannins, ellagic acid) in specific ratios and concentrations. This composite provides synergistic anti-viral effects that are more effective than individual compounds or traditional pomegranate juice alone
2Reliability
If existing antioxidants are used to prevent influenza, then they provide general antioxidant support, but they fail to address the high mutation rate and cross-species transmission of influenza viruses due to antigenic drift
Solution Approach 1:
The patent changes the concentration parameter of polyphenols, specifically achieving punicalagin concentrations up to 100 times higher than in commercial pomegranate juice. This parameter change transforms the composition from a general antioxidant supplement to a potent anti-viral agent capable of overcoming influenza's mutation rate and providing reliable prophylactic protection
Solution Approach 2:
The patent employs a composite of multiple polyphenolic compounds with different molecular weights and structures, creating a multi-target antioxidant system that can address various viral mechanisms and mutations simultaneously, thereby improving adaptability against antigenic drift
3Quantity of substance
If pomegranate solids are processed to extract phytochemicals, then the extraction process requires multiple steps including heating and enzymatic treatment, but this complexity is necessary to liberate high molecular weight polyphenols effectively
Solution Approach 1:
The patent applies preliminary enzymatic treatment to pomegranate solids before extraction to break down cell walls and liberate bound polyphenols. This preliminary action simplifies subsequent extraction steps and enables effective recovery of high molecular weight compounds that would otherwise remain trapped in the solid matrix
Solution Approach 2:
The patent utilizes controlled heating at specific temperature ranges to optimize the extraction efficiency of high molecular weight polyphenols while preventing degradation. This parameter optimization balances the complexity of the process with the need to effectively liberate and preserve thermally sensitive phytochemicals
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The pomegranate extract composition demonstrates significant antiviral properties, effectively reducing the incidence of influenza virus infections by inhibiting viral replication and providing a broad spectrum of polyphenols, including high molecular weight compounds like punicalagin, which are more effective than traditional pomegranate juice.
Implementation Method 1
Enzymes are added to the mixture in an amount sufficient to at least partially degrade the pomegranate solids and liberate phytochemicals from the plant tissues and/or cells
Implementation Method 2
The mixture is then heated to about 60° F. to 210° F., preferably of about 85° F. to 185° F. and optimally of about 110° F. to 160° F.
Data Source
AI summary
Methods and compositions for treating at least one symptom of a viral infection, said method of treatment comprising administering to a subject with a least one symptom of a viral infection an effective dosage unit of a composition comprising pomegranate extract. The compositions comprise pomegranate extract comprising polyphenols. The composition is produced by a process comprising providing one or more pomegranate solids selected from the group consisting of a pericarp, inner membrane and seeds, creating a mixture comprising said one or more pomegranate solids in an aqueous solution, heating said mixture to a temperature that permits enzyme catalysis of said pomegranate solids, and removing residual insoluble solid materials from said mixture to provide said pomegranate extract. Compositions containing the extract may be used as a food product, beverage, pharmaceutical preparations, nutritional supplements, vitamin supplements, food additives, and food supplements.